INCY Covered Call Strategy
INCY (Incyte Corporation), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Incyte Corporation is a biopharmaceutical firm engaged in the research, development, and global marketing of its own innovative therapies. Its current product offerings include JAKAFI, prescribed for myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that targets oncogenic drivers in various liquid and solid tumor types; and ICLUSIG, a kinase inhibitor utilized for chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. Beyond its marketed drugs, Incyte's pipeline features several promising candidates. Among its clinical-stage assets are ruxolitinib, targeting steroid-refractory chronic graft-versus-host disease (GVHD), and itacitinib, which is undergoing Phase II/III trials for newly diagnosed chronic GVHD. Pemigatinib is also being investigated for conditions such as bladder cancer, cholangiocarcinoma, myeloproliferative syndrome, and other tumor types. Further advancing its research, the company is developing Parsaclisib, currently in Phase II studies for follicular lymphoma, marginal zone lymphoma, and mantle cell lymphoma.
INCY (Incyte Corporation) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $22.73B, a trailing P/E of 15.84, a beta of 0.79 versus the broader market, a 52-week range of 66.83-115.56, average daily share volume of 1.7M, a public-listing history dating back to 1993, approximately 3K full-time employees. These structural characteristics shape how INCY stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.79 places INCY roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a covered call on INCY?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current INCY snapshot
As of June 29, 2026, spot at $114.53, ATM IV 31.90%, IV rank 21.05%, expected move 9.15%. The covered call on INCY below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this covered call structure on INCY specifically: INCY IV at 31.90% is on the cheap side of its 1-year range, which means a premium-selling INCY covered call collects less credit per unit of strike-width risk, with a market-implied 1-standard-deviation move of approximately 9.15% (roughly $10.47 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated INCY expiries trade a higher absolute premium for lower per-day decay. Position sizing on INCY should anchor to the underlying notional of $114.53 per share and to the trader's directional view on INCY stock.
INCY covered call setup
The INCY covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With INCY near $114.53, the first option leg uses a $120.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed INCY chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 INCY shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $114.53 | long |
| Sell 1 | Call | $120.00 | $1.35 |
INCY covered call risk and reward
- Net Premium / Debit
- -$11,318.00
- Max Profit (per contract)
- $682.00
- Max Loss (per contract)
- -$11,317.00
- Breakeven(s)
- $113.18
- Risk / Reward Ratio
- 0.060
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
INCY covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on INCY. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | -$11,317.00 |
| $25.33 | -77.9% | -$8,784.79 |
| $50.65 | -55.8% | -$6,252.58 |
| $75.98 | -33.7% | -$3,720.37 |
| $101.30 | -11.6% | -$1,188.16 |
| $126.62 | +10.6% | +$682.00 |
| $151.94 | +32.7% | +$682.00 |
| $177.26 | +54.8% | +$682.00 |
| $202.59 | +76.9% | +$682.00 |
| $227.91 | +99.0% | +$682.00 |
When traders use covered call on INCY
Covered calls on INCY are an income strategy run on existing INCY stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
INCY thesis for this covered call
The market-implied 1-standard-deviation range for INCY extends from approximately $104.06 on the downside to $125.00 on the upside. A INCY covered call collects premium on an existing long INCY position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether INCY will breach that level within the expiration window. Current INCY IV rank near 21.05% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on INCY at 31.90%. As a Healthcare name, INCY options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to INCY-specific events.
INCY covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. INCY positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move INCY alongside the broader basket even when INCY-specific fundamentals are unchanged. Short-premium structures like a covered call on INCY carry tail risk when realized volatility exceeds the implied move; review historical INCY earnings reactions and macro stress periods before sizing. Always rebuild the position from current INCY chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on INCY?
- A covered call on INCY is the covered call strategy applied to INCY (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With INCY stock trading near $114.53, the strikes shown on this page are snapped to the nearest listed INCY chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are INCY covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the INCY covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 31.90%), the computed maximum profit is $682.00 per contract and the computed maximum loss is -$11,317.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a INCY covered call?
- The breakeven for the INCY covered call priced on this page is roughly $113.18 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current INCY market-implied 1-standard-deviation expected move is approximately 9.15%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on INCY?
- Covered calls on INCY are an income strategy run on existing INCY stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current INCY implied volatility affect this covered call?
- INCY ATM IV is at 31.90% with IV rank near 21.05%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.